Tianda Pharmaceuticals (HKSE:00455) EV-to-EBITDA : -22.72 (As of May. 25, 2024)

Tianda Pharmaceuticals EV-to-EBITDA Chart

Tianda Pharmaceuticals Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Dec23
EV-to-EBITDA		Get a 7-Day Free Trial					2.53	2.80	-60.54	-67.09	26.80

Tianda Pharmaceuticals Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															-	-67.09	-	-	26.80

Competitive Comparison of Tianda Pharmaceuticals's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Tianda Pharmaceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianda Pharmaceuticals's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianda Pharmaceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tianda Pharmaceuticals's EV-to-EBITDA falls into.

Tianda Pharmaceuticals EV-to-EBITDA Calculation

Tianda Pharmaceuticals's EV-to-EBITDA for today is calculated as:

Tianda Pharmaceuticals's current Enterprise Value is HK$471.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tianda Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-20.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianda Pharmaceuticals  (HKSE:00455) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Tianda Pharmaceuticals's PE Ratio for today is calculated as:

Tianda Pharmaceuticals's share price for today is HK$0.242.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tianda Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.011.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Tianda Pharmaceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianda Pharmaceuticals (HKSE:00455) Business Description